摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-ethyl 3-(naphthalen-2-yl)-3-phenylacrylate | 133263-84-0

中文名称
——
中文别名
——
英文名称
(E)-ethyl 3-(naphthalen-2-yl)-3-phenylacrylate
英文别名
ethyl (E)-3-(naphthalen-2-yl)-3-phenylacrylate;3-[2]naphthyl-3-phenyl-acrylic acid ethyl ester;3-[2]Naphthyl-3-phenyl-acrylsaeure-aethylester;ethyl (E)-3-(2-naphthyl)-3-phenylacrylate;ethyl (E)-3-naphthalen-2-yl-3-phenylprop-2-enoate
(E)-ethyl 3-(naphthalen-2-yl)-3-phenylacrylate化学式
CAS
133263-84-0
化学式
C21H18O2
mdl
——
分子量
302.373
InChiKey
JKWYZCLAZIHLNT-HMMYKYKNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.7
  • 重原子数:
    23
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (E)-ethyl 3-(naphthalen-2-yl)-3-phenylacrylate甲基二乙氧基硅烷 、 C22H31N2O7Rh 、 盐酸 作用下, 以 甲苯四氢呋喃甲醇 为溶剂, 反应 3.0h, 以96%的产率得到(S)-ethyl 3-(naphthalen-2-yl)-3-phenylpropanoate
    参考文献:
    名称:
    Enantioselective Synthesis of Optically Active 3,3-Diarylpropanoates by Conjugate Hydrosilylation with Chiral Rh-bis(oxazolinyl)phenyl Catalysts
    摘要:
    Conjugate hydrosilylation of 3,3-diarylacrylate derivatives catalyzed by chiral rhodium-bis(oxazolinyl)phenyl complexes (1 mol %) at 60 degrees C for 2 h was investigated to prepare optically active 3,3-diarylpropanoate derivatives in high yields up to 99% yield and high enantioselectivities up to 99%.
    DOI:
    10.1021/jo302357b
  • 作为产物:
    描述:
    alkaline earth salt of/the/ methylsulfuric acid 在 磷酸酐 作用下, 生成 (E)-ethyl 3-(naphthalen-2-yl)-3-phenylacrylate
    参考文献:
    名称:
    de Fazi, Gazzetta Chimica Italiana, 1919, vol. 49 II, p. 259
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Rh-Catalyzed Asymmetric Hydrogenation of β-Branched Enol Esters for the Synthesis of β-Chiral Primary Alcohols
    作者:Chong Liu、Jing Yuan、Jian Zhang、Zhihui Wang、Zhenfeng Zhang、Wanbin Zhang
    DOI:10.1021/acs.orglett.7b03469
    日期:2018.1.5
    An asymmetric hydrogenation of β-branched enol esters has been developed for the first time, providing a new route for the synthesis of β-chiral primary alcohols. Using a (S)-SKP-Rh complex bearing a large bite angle and enol ester substrates possessing an O-fomyl directing group, the desired products were obtained in quantitative yields and with excellent enantioselectivities.
    首次开发了β-支链烯醇酯的不对称氢化,为合成β-手性伯醇提供了新途径。使用具有大咬合角的(S)-SKP-Rh配合物和具有O-甲酰基导向基团的烯醇酯底物,以定量收率和优异的对映选择性获得了所需产物。
  • Rhodium(I)-Catalyzed Enantioselective Hydrogenation of Substituted Acrylic Acids with Sterically Similar β,β-Diaryls
    作者:Yang Li、Kaiwu Dong、Zheng Wang、Kuiling Ding
    DOI:10.1002/anie.201302349
    日期:2013.6.24
    Distinct differentiation: β,β‐Disubstituted acrylic acids with sterically similar geminal diaryl groups can be hydrogenated with excellent enantioselectivities in the presence of a RhI complex formed in situ with two‐component ligands, a chiral secondary phosphine oxide (SPO) and an achiral phosphine (Ph3P). The sense of asymmetric induction was found to be controlled by the substrate configuration
    独特的区别:在具有双组分配体,手性仲氧化膦(SPO)和非手性原位形成的Rh I配合物存在下,具有相似的双键双芳基基团的β,β-二取代丙烯酸可以出色的对映选择性进行氢化膦(Ph 3 P)。发现不对称诱导的感觉受底物构型控制,因此允许使用相同的催化剂接近产物的两种对映异构体。
  • Chiral dihydrobenzo[1,4]oxazines as catalysts for the asymmetric transfer-hydrogenation of α,β-unsaturated aldehydes
    作者:Christian Ebner、Andreas Pfaltz
    DOI:10.1016/j.tet.2011.10.051
    日期:2011.12
    A new class of organocatalysts based on the structure of 2,3-dihydrobenzo[1,4]oxazine was prepared and applied in the enantioselective transfer-hydrogenation of α,β-unsaturated aldehydes with Hantzsch ester as hydride donor. These catalysts proved to be particularly effective for the conjugate reduction of β,β-diaryl-substituted acrylaldehydes leading to saturated aldehydes bearing a stereogenic center
    制备了一种基于2,3-二氢苯并[1,4]恶嗪结构的新型有机催化剂,并将其用于以Hantzsch酯为氢化物供体的α,β-不饱和醛的对映选择性转移加氢。这些催化剂被证明对于共轭还原β,β-二芳基取代的丙烯醛特别有效,从而导致带有两个立体不同的芳基的立体异构中心的立体醛,对映选择性高达91%ee。
  • Controlling Enantioselectivity and Diastereoselectivity in Radical Cascade Cyclization for Construction of Bicyclic Structures
    作者:Congzhe Zhang、Duo-Sheng Wang、Wan-Chen Cindy Lee、Alexander M. McKillop、X. Peter Zhang
    DOI:10.1021/jacs.1c04719
    日期:2021.7.28
    controlling enantioselectivity as well as diastereoselectivity in radical cascade cyclization, we herein report the development of a Co(II)-based catalytic system for asymmetric radical bicyclization of 1,6-enynes with diazo compounds. Through the fine-tuning of D2-symmetric chiral amidoporphyrins as the supporting ligands, the Co(II)-catalyzed radical cascade process, which proceeds in a single operation under
    自由基级联环化反应是有机合成中构建多环分子的极具吸引力的合成工具。虽然它已成功应用于天然产物和其他复杂化合物的非对映选择性合成,但自由基级联环化面临着控制对映选择性的重大挑战。作为属自由基催化(MRC)在自由基级联环化中控制对映选择性和非对映选择性的首次应用,我们在此报告了一种基于Co(II)的催化系统的开发,用于1,6-烯炔与重氮化合物的不对称自由基双环化。通过对D 2 -对称手性酰胺卟啉作为支持配体的微调,Co(II)催化的自由基级联过程在温和条件下单次操作进行,能够不对称构建带有三个连续的多取代环丙烷稠合四氢呋喃。立体异构中心,包括两个全碳四元中心,产量高且具有优异的立体选择性。结合计算和实验研究揭示了这种新的基于 Co(II) 的级联双环化的潜在逐步自由基机制,该机制涉及几种 Co-支持的 C 中心自由基中间体的中继,包括 α-、β-、γ-、和ε-属烷基自由基。所得到的对映体富
  • N-acryloylpiperazine derivatives, their preparation and their use as PAF
    申请人:Sankyo Company, Limited
    公开号:US05192766A1
    公开(公告)日:1993-03-09
    Compounds of formula (I): ##STR1## wherein R.sup.1 and R.sup.2 is each --R.sup.5, --CH.dbd.CH--R.sup.5 or --C.tbd.C--R.sup.5, wherein R.sup.5 is optionally substituted aryl or aromatic heterocyclic; R.sup.3 is hydrogen, alkyl, cyano or --R.sup.5 ; X is oxygen or sulfur; A is 1,4-piperazin-1,4-diyl or a 1,4-homopiperazin-1,4-diyl; B' is alkylene, carbonyl, thiocarbonyl, sulfinyl or sulfonyl; and R.sup.4 is optionally substituted phenyl and pharmaceutically acceptable salts thereof have valuable PAF antagonist activity, and may be prepared by reacting a compound containing the piperazine or homopiperazine part of the molecular with a compound containing the other part of the molecule.
    式(I)的化合物:其中R.sup.1和R.sup.2分别为--R.sup.5,--CH.dbd.CH--R.sup.5或--C.tbd.C--R.sup.5,其中R.sup.5是可选择取代的芳基或芳香杂环基;R.sup.3是氢,烷基,基或--R.sup.5;X是氧或;A是1,4-哌嗪-1,4-二基或1,4-同源哌嗪-1,4-二基;B'是烷基,羰基,代羰基,砜基或磺酰基;R.sup.4是可选择取代的苯基和其药用盐具有有价值的PAF拮抗活性,可以通过将含有分子中哌嗪或同源哌嗪部分的化合物与含有分子的其他部分的化合物反应来制备。
查看更多